New preclinical findings provide validation for Silexion’s new systemic administration approach for SIL-204, demonstrating ...

根据国际癌症研究数据显示，胰腺癌（Pancreatic ...

【导读】胰腺癌肝转移是导致预后不良的一个重要因素。肝转移中适应性免疫重塑的细节，尤其是中性粒细胞的作用，仍然难以捉摸。在这项研究中，单细胞测序与空间转录组学相结合的结果显示，与原发肿瘤相比，肝转移瘤表现出更具侵袭性的转录特征和更高水平的免疫抑制。20 ...

Pancreas cells may produce a protein that can protect the brain from Alzheimer's disease. In individuals with Alzheimer's ...

Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five ...

1. Nature研究报道揭示白细胞介素-33 (IL-33)激活天然淋巴细胞 (ILC2s)诱导胰腺癌三级淋巴结构 (TLSs)的形成，为胰腺癌治疗带来新希望。 PDAC肿瘤中的TLS特征相关性（a, 上图）： ...

A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body forms immune cell ...

Silexion Therapeutics' SIL-204 exhibits synergy with key pancreatic cancer drugs in preclinical studies. Phase 2/3 trials ...

SAN FRANCISCO -- Older patients' survival in metastatic pancreatic cancer had a significant association with baseline ...

In the next step, the researchers want to develop new molecules based on digoxin that are even better at dissolving the CTC clusters.